Menu
Back to User profile » Dr Anselmo Papa
Papers published by Dr Anselmo Papa:
Triple-negative breast cancer: new perspectives for targeted therapies
Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S
OncoTargets and Therapy 2015, 8:177-193
Published Date: 16 January 2015
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S
Cancer Management and Research 2013, 5:377-385
Published Date: 19 November 2013
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S
Therapeutics and Clinical Risk Management 2013, 9:457-462
Published Date: 11 November 2013
Current status of bevacizumab in advanced ovarian cancer
Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
OncoTargets and Therapy 2013, 6:889-899
Published Date: 22 July 2013
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S
OncoTargets and Therapy 2012, 5:199-211
Published Date: 24 September 2012